Aspen Aerogels Inc
NYSE:ASPN

Watchlist Manager
Aspen Aerogels Inc Logo
Aspen Aerogels Inc
NYSE:ASPN
Watchlist
Price: 6.38 USD 3.4% Market Closed
Market Cap: 523.8m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ASPN stock under the Base Case scenario is 11.71 USD. Compared to the current market price of 6.38 USD, Aspen Aerogels Inc is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ASPN Relative Value
Base Case
11.71 USD
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.2
P/S
P/S
Price to Sales
1.2
vs History
93
vs Industry
48
Median 3Y
3.3
Median 5Y
3.6
Industry
1.4
Forward
1.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
17
Median 3Y
-6.3
Median 5Y
-13.8
Industry
20.7
Forward
-15.9
More Details
7.6
P/OCF
P/OCF
Price to OCF
7.6
vs History
14
vs Industry
37
Median 3Y
-7.3
Median 5Y
-19.6
Industry
13.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-16.7
Industry
20.8
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
77
vs Industry
65
Median 3Y
1.9
Median 5Y
2.7
Industry
1.6
More Details
1.1
EV/S
EV/S
Enterprise Value to Sales
1.1
vs History
95
vs Industry
56
Median 3Y
2.9
Median 5Y
3.5
Industry
1.6
Forward
1.5
More Details
2.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.7
vs History
85
vs Industry
71
Median 3Y
14.2
Median 5Y
17.3
Industry
6.9
More Details
6.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.5
vs History
15
vs Industry
56
Median 3Y
-6.7
Median 5Y
-16.6
Industry
12.5
Forward
12.7
More Details
9.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.4
vs History
15
vs Industry
55
Median 3Y
-5.8
Median 5Y
-13.2
Industry
17
Forward
-2.6
More Details
6.8
EV/OCF
EV/OCF
Enterprise Value to OCF
6.8
vs History
14
vs Industry
42
Median 3Y
-6.1
Median 5Y
-16.9
Industry
14.2
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-17
Industry
20.1
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
80
vs Industry
63
Median 3Y
1.8
Median 5Y
2.4
Industry
1.3
More Details

Multiples Across Competitors

ASPN Competitors Multiples
Aspen Aerogels Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Aspen Aerogels Inc
NYSE:ASPN
524.3m USD 1.2 -1.8 6.5 9.4
JP
JSR Corp
TSE:4185
601.9T JPY 1 487.5 -108 426.4 16 236.1 169 298.1
US
Sherwin-Williams Co
NYSE:SHW
90.4B USD 3.9 33.7 22.6 26.3
US
Ecolab Inc
NYSE:ECL
76.4B USD 4.9 36.3 22.9 30.9
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
9T JPY 3.5 16.9 7.3 9.7
CH
Givaudan SA
SIX:GIVN
38.6B CHF 5.2 35.4 23.7 29.8
CH
DSM-Firmenich AG
AEX:DSFIR
26.3B EUR 2.1 105 14.1 50
US
Dupont De Nemours Inc
NYSE:DD
29.3B USD 2.3 -391 9.8 15.2
US
PPG Industries Inc
NYSE:PPG
26.1B USD 1.7 24 13.1 16.5
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.1T INR 6.3 58 34.8 42
P/E Multiple
Earnings Growth PEG
US
Aspen Aerogels Inc
NYSE:ASPN
Average P/E: 45.5
Negative Multiple: -1.8
75%
N/A
JP
JSR Corp
TSE:4185
Negative Multiple: -108 426.4 N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
33.7
12%
2.8
US
Ecolab Inc
NYSE:ECL
36.3
9%
4
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
16.9
N/A N/A
CH
Givaudan SA
SIX:GIVN
35.4
8%
4.4
CH
D
DSM-Firmenich AG
AEX:DSFIR
105
77%
1.4
US
Dupont De Nemours Inc
NYSE:DD
Negative Multiple: -391
46%
N/A
US
PPG Industries Inc
NYSE:PPG
24
24%
1
DK
Novozymes A/S
CSE:NZYM B
54.8
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
58
14%
4.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Aspen Aerogels Inc
NYSE:ASPN
Average EV/EBITDA: 1 492.7
6.5
19%
0.3
JP
JSR Corp
TSE:4185
16 236.1
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
22.6
9%
2.5
US
Ecolab Inc
NYSE:ECL
22.9
9%
2.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
7.3
6%
1.2
CH
Givaudan SA
SIX:GIVN
23.7
6%
4
CH
D
DSM-Firmenich AG
AEX:DSFIR
14.1
11%
1.3
US
Dupont De Nemours Inc
NYSE:DD
9.8
8%
1.2
US
PPG Industries Inc
NYSE:PPG
13.1
5%
2.6
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
34.8
10%
3.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Aspen Aerogels Inc
NYSE:ASPN
Average EV/EBIT: 15 415.1
9.4
13%
0.7
JP
JSR Corp
TSE:4185
169 298.1
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
26.3
10%
2.6
US
Ecolab Inc
NYSE:ECL
30.9
11%
2.8
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
9.7
N/A N/A
CH
Givaudan SA
SIX:GIVN
29.8
7%
4.3
CH
D
DSM-Firmenich AG
AEX:DSFIR
50
412%
0.1
US
Dupont De Nemours Inc
NYSE:DD
15.2
18%
0.8
US
PPG Industries Inc
NYSE:PPG
16.5
6%
2.7
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
42
10%
4.2

See Also

Summary
ASPN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ASPN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ASPN stock valuation using valuation multiples.
Wall Street Estimates
ASPN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ASPN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 260,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.